Laura Hulea

3.8k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

Laura Hulea is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Laura Hulea has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Laura Hulea's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Laura Hulea is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Laura Hulea collaborates with scholars based in Canada, United States and Sweden. Laura Hulea's co-authors include Ivan Topisirović, Nahum Sonenberg, Jerry Pelletier, Nathaniel Robichaud, Mamatha Bhat, Julie St‐Pierre, Ola Larsson, Michaël Pollak, Masahiro Morita and Simon‐Pierre Gravel and has published in prestigious journals such as Nature Communications, Molecular Cell and Nature Reviews Drug Discovery.

In The Last Decade

Laura Hulea

19 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the translation machinery in cancer

2015 597 citations Mamatha Bhat, Nathaniel Robichaud et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Hulea Canada	14	1.6k	403	213	177	161	21	2.0k
Don Benjamin Switzerland	12	1.2k 0.8×	347 0.9×	202 0.9×	207 1.2×	205 1.3×	14	1.7k
Hyonchol Jang South Korea	25	1.5k 0.9×	520 1.3×	245 1.2×	149 0.8×	178 1.1×	66	1.9k
Heather R. Keys United States	13	1.7k 1.1×	384 1.0×	257 1.2×	177 1.0×	199 1.2×	17	2.3k
Bruno D. Fonseca Canada	15	1.6k 1.0×	235 0.6×	208 1.0×	282 1.6×	202 1.3×	16	2.1k
Qinxi Li China	22	1.1k 0.7×	314 0.8×	287 1.3×	289 1.6×	193 1.2×	39	1.5k
Petra Obexer Austria	24	1.2k 0.8×	325 0.8×	396 1.9×	175 1.0×	248 1.5×	43	1.8k
Mohammad Fallahi United States	26	1.2k 0.8×	272 0.7×	264 1.2×	117 0.7×	281 1.7×	41	1.9k
Min Ju Kang South Korea	22	1.3k 0.8×	638 1.6×	309 1.5×	116 0.7×	138 0.9×	43	1.8k
Lan Kang China	22	1.8k 1.1×	286 0.7×	243 1.1×	77 0.4×	118 0.7×	72	2.2k
José Manuel García-Manteiga Italy	23	893 0.6×	336 0.8×	349 1.6×	137 0.8×	263 1.6×	44	1.7k

Countries citing papers authored by Laura Hulea

Since Specialization

Citations

This map shows the geographic impact of Laura Hulea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hulea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hulea more than expected).

Fields of papers citing papers by Laura Hulea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hulea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hulea. The network helps show where Laura Hulea may publish in the future.

Co-authorship network of co-authors of Laura Hulea

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hulea. A scholar is included among the top collaborators of Laura Hulea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hulea. Laura Hulea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercier, François, et al.. (2025). Translational control of leukemic metabolism and disease progression. Trends in Cell Biology. 35(11). 971–986.

Siqueira, Mirian Krystel De, Siqi Wang, Xinshu Xiao, et al.. (2025). Protocol to perform polysome profiling in primary differentiating murine adipocytes. STAR Protocols. 6(2). 103799–103799.

Chidiac, Rony, Chantal Delisle, Gaël Cagnone, et al.. (2024). ZO-1 interacts with YB-1 in endothelial cells to regulate stress granule formation during angiogenesis. Nature Communications. 15(1). 4405–4405. 15 indexed citations

Nair, Remya, Ronald A. Merrill, Catherine St‐Louis, et al.. (2023). The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. Blood Advances. 7(14). 3485–3500. 9 indexed citations

Galicia-Vázquez, Gabriela, Alejandro Schcolnik‐Cabrera, Vincent Luo, et al.. (2022). EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. Journal of Experimental & Clinical Cancer Research. 41(1). 340–340. 13 indexed citations

Zhdanov, Alexander V., Predrag Jovanović, Ye Wang, et al.. (2022). Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells. FEBS Open Bio. 12(5). 959–982. 7 indexed citations

Papadopoli, David, et al.. (2021). Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin. Neoplasia. 23(4). 391–399. 40 indexed citations

Pollak, Michaël, et al.. (2018). Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia. Journal of Molecular Endocrinology. 62(2). R83–R103. 8 indexed citations

Hulea, Laura, Simon‐Pierre Gravel, Masahiro Morita, et al.. (2018). Translational and HIF11-Dependent Metabolic Reprograming Underpin Oncometabolome Plasticity and Synergy Between Oncogenic Kinase Inhibitors and Biguanides. SSRN Electronic Journal. 1 indexed citations

10.

Morita, Masahiro, Julien Prudent, Kaustuv Basu, et al.. (2017). mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1. Molecular Cell. 67(6). 922–935.e5. 262 indexed citations

11.

Masvidal, Laìa, Laura Hulea, Luc Furic, Ivan Topisirović, & Ola Larsson. (2017). mTOR-sensitive translation: Cleared fog reveals more trees. RNA Biology. 14(10). 1299–1305. 50 indexed citations

12.

Gandin, Valentina, Laìa Masvidal, Laura Hulea, et al.. (2016). nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs. Genome Research. 26(5). 636–648. 144 indexed citations

13.

Hulea, Laura, Zoran Marković, Ivan Topisirović, Thomas Simmet, & Vladimir Trajković. (2016). Biomedical Potential of mTOR Modulation by Nanoparticles. Trends in biotechnology. 34(5). 349–353. 29 indexed citations

14.

Lalonde, Marie‐Eve, Marie-Anne Germain, Marie‐Christine Guiot, et al.. (2016). The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nature Communications. 7(1). 12700–12700. 137 indexed citations

15.

Feng, Yongmei, Anthony B. Pinkerton, Laura Hulea, et al.. (2015). SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. Cancer Research. 75(24). 5211–5218. 26 indexed citations

16.

Bhat, Mamatha, Nathaniel Robichaud, Laura Hulea, et al.. (2015). Targeting the translation machinery in cancer. Nature Reviews Drug Discovery. 14(4). 261–278. 597 indexed citations breakdown →

17.

Morita, Masahiro, Simon‐Pierre Gravel, Laura Hulea, et al.. (2015). mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 14(4). 473–480. 401 indexed citations

18.

Ramdzan, Zubaidah M., Charles Vadnais, Ranjana Pal, et al.. (2014). RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. PLoS Biology. 12(3). e1001807–e1001807. 53 indexed citations

19.

Gravel, Simon‐Pierre, Laura Hulea, Elena Birman, et al.. (2014). Serine Deprivation Enhances Antineoplastic Activity of Biguanides. Cancer Research. 74(24). 7521–7533. 105 indexed citations

20.

Hulea, Laura & Alain Nepveu. (2012). CUX1 transcription factors: From biochemical activities and cell-based assays to mouse models and human diseases. Gene. 497(1). 18–26. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact